首页 > 最新文献

Journal of Integrative Medicine-Jim最新文献

英文 中文
Electroacupuncture alleviates behaviors associated with posttraumatic stress disorder by modulating lipocalin-2-mediated neuroinflammation and neuronal activity in the prefrontal cortex 电针通过调节脂钙素-2介导的神经炎症和前额叶皮层的神经元活动,减轻与创伤后应激障碍相关的行为。
IF 4 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 DOI: 10.1016/j.joim.2025.07.002
Yu-die Yang , Wen Zhong , Ming Chen , Qing-chen Tang , Yan Li , Lu-lu Yao , Mei-qi Zhou , Neng-gui Xu , Shuai Cui

Objective

To elucidate the specific mechanisms by which electroacupuncture (EA) alleviates anxiety and fear behaviors associated with posttraumatic stress disorder (PTSD), focusing on the role of lipocalin-2 (Lcn2).

Methods

The PTSD mouse model was subjected to single prolonged stress and shock (SPS&S), and the animals received 15 min sessions of EA at Shenmen acupoint (HT7). Behavioral tests were used to investigate the effects of EA at HT7 on anxiety and fear. Western blotting and enzyme-linked immunosorbent assay were used to quantify Lcn2 and inflammatory cytokine levels in the prefrontal cortex (PFC). Additionally, the activity of PFC neurons was evaluated by immunofluorescence and in vivo electrophysiology.

Results

Mice subjected to SPS&S presented increased anxiety- and fear-like behaviors. Lcn2 expression in the PFC was significantly upregulated following SPS&S, leading to increased expression of the proinflammatory cytokines tumor necrosis factor-α and interleukin-6 and suppression of PFC neuronal activity. However, EA at HT7 inhibited Lcn2 release, reducing neuroinflammation and hypoexcitability in the PFC. Lcn2 overexpression mitigated the effects of EA at HT7, resulting in anxiety- and fear-like behaviors.

Conclusion

EA at HT7 can ameliorate PTSD-associated anxiety and fear, and its mechanism of action appears to involve the inhibition of Lcn2-mediated neural activity and inflammation in the PFC.
Please cite this article as: Yang YD, Zhong W, Chen M, Tang QC, Li Y, Yao LL, et al. Electroacupuncture alleviates behaviors associated with posttraumatic stress disorder by modulating lipocalin-2-mediated neuroinflammation and neuronal activity in the prefrontal cortex. J Integr Med. 2025; 23(5):537–547.
目的:探讨电针(EA)缓解创伤后应激障碍(PTSD)患者焦虑和恐惧行为的具体机制,重点研究脂脂素-2 (Lcn2)在其中的作用。方法:创伤后应激障碍(PTSD)小鼠模型单次延长应激休克(SPS&S),并在神门穴(HT7)进行15 min的EA治疗。采用行为测试研究HT7时EA对焦虑和恐惧的影响。采用Western blotting和酶联免疫吸附法测定前额皮质(PFC)中Lcn2和炎症细胞因子的水平。此外,采用免疫荧光和体内电生理方法评估PFC神经元的活性。结果:SPS&S小鼠表现出增加的焦虑和恐惧样行为。SPS&S后PFC中Lcn2的表达显著上调,导致促炎细胞因子肿瘤坏死因子-α和白细胞介素-6的表达增加,PFC神经元活性抑制。然而,HT7的EA抑制了Lcn2的释放,减少了pfc的神经炎症和低兴奋性。Lcn2过表达减轻了HT7 EA的作用,导致焦虑和恐惧样行为。结论:HT7 EA可改善创伤后应激障碍相关的焦虑和恐惧,其作用机制可能与抑制lcn2介导的pfa神经活动和炎症有关。请引用本文:杨延东,钟伟,陈敏,唐国强,李勇,姚丽玲,等。电针通过调节脂钙素-2介导的神经炎症和前额叶皮层的神经元活动,减轻与创伤后应激障碍相关的行为。集成医学[J];打印前Epub。
{"title":"Electroacupuncture alleviates behaviors associated with posttraumatic stress disorder by modulating lipocalin-2-mediated neuroinflammation and neuronal activity in the prefrontal cortex","authors":"Yu-die Yang ,&nbsp;Wen Zhong ,&nbsp;Ming Chen ,&nbsp;Qing-chen Tang ,&nbsp;Yan Li ,&nbsp;Lu-lu Yao ,&nbsp;Mei-qi Zhou ,&nbsp;Neng-gui Xu ,&nbsp;Shuai Cui","doi":"10.1016/j.joim.2025.07.002","DOIUrl":"10.1016/j.joim.2025.07.002","url":null,"abstract":"<div><h3>Objective</h3><div>To elucidate the specific mechanisms by which electroacupuncture (EA) alleviates anxiety and fear behaviors associated with posttraumatic stress disorder (PTSD), focusing on the role of lipocalin-2 (Lcn2).</div></div><div><h3>Methods</h3><div>The PTSD mouse model was subjected to single prolonged stress and shock (SPS&amp;S), and the animals received 15 min sessions of EA at Shenmen acupoint (HT7). Behavioral tests were used to investigate the effects of EA at HT7 on anxiety and fear. Western blotting and enzyme-linked immunosorbent assay were used to quantify Lcn2 and inflammatory cytokine levels in the prefrontal cortex (PFC). Additionally, the activity of PFC neurons was evaluated by immunofluorescence and in vivo electrophysiology.</div></div><div><h3>Results</h3><div>Mice subjected to SPS&amp;S presented increased anxiety- and fear-like behaviors. Lcn2 expression in the PFC was significantly upregulated following SPS&amp;S, leading to increased expression of the proinflammatory cytokines tumor necrosis factor-α and interleukin-6 and suppression of PFC neuronal activity. However, EA at HT7 inhibited Lcn2 release, reducing neuroinflammation and hypoexcitability in the PFC. Lcn2 overexpression mitigated the effects of EA at HT7, resulting in anxiety- and fear-like behaviors.</div></div><div><h3>Conclusion</h3><div>EA at HT7 can ameliorate PTSD-associated anxiety and fear, and its mechanism of action appears to involve the inhibition of Lcn2-mediated neural activity and inflammation in the PFC.</div><div>Please cite this article as: Yang YD, Zhong W, Chen M, Tang QC, Li Y, Yao LL, et al. Electroacupuncture alleviates behaviors associated with posttraumatic stress disorder by modulating lipocalin-2-mediated neuroinflammation and neuronal activity in the prefrontal cortex. <em>J Integr Med</em>. 2025; 23(5):537–547.</div></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"23 5","pages":"Pages 537-547"},"PeriodicalIF":4.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144692023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Salvia miltiorrhiza components and gut microbiota interactions in Helicobacter pylori infection 幽门螺杆菌感染中丹参成分与肠道菌群的相互作用。
IF 4 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 DOI: 10.1016/j.joim.2025.07.006
Shao-jian Li , Jin-xin Miao , Fei Wang , Hao-yu Wang , Yao-wu Ma , Ying Jiang , Xia Xue
Salvia miltiorrhiza (Danshen) is a traditional Chinese herb that is commonly known for its cardiovascular and hepatoprotective benefits. Recent studies have confirmed that Danshen and its bioactive components can influence gut microbial homeostasis, thereby affecting Helicobacter pylori (HP) colonization in the human stomach. HP is a bacterial pathogen associated with various gastrointestinal diseases. Current HP treatments mainly involve antibiotics and proton pump inhibitors. However, their efficacy is strongly compromised by the rapid emergence of antibiotic resistance in HP and genetic heterogeneity among patients. The interaction between Danshen and gut microbial status provides a novel perspective for HP treatment. Understanding the medical properties of Danshen in altering gut microbiota and eliminating HP, as well as the underlying mechanisms, is important for improving human gastrointestinal healthcare. This review investigates the interaction between Danshen and gut microbiota and its impact on HP infection using databases including Web of Science, PubMed, and Google Scholar. We explored the unconventional intersection between Danshen, gut microbiota, and HP infection, shedding light on their intricate interplay and potential therapeutic implications. A comprehensive understanding of this interaction provides valuable insights into developing novel therapeutic strategies that target the gut microbiota to mitigate HP-associated gastrointestinal disorders.

Please cite this article as: Li SJ, Miao JX, Wang F, Wang HY, Ma YW, Jiang Y, Xue X. Salvia miltiorrhiza components and gut microbiota interactions in Helicobacter pylori infection. J Integr Med. 2025; 23(5):462–470.
丹参是一种传统的中国草药,以其心血管和肝脏保护作用而闻名。近年来的研究证实,丹参及其生物活性成分可以影响肠道微生物稳态,从而影响幽门螺杆菌(Helicobacter pylori, HP)在人胃中的定植。HP是一种与多种胃肠道疾病相关的细菌病原体。目前HP的治疗主要包括抗生素和质子泵抑制剂。然而,由于HP中抗生素耐药性的迅速出现和患者之间的遗传异质性,它们的疗效受到严重影响。丹参与肠道微生物状态的相互作用为HP的治疗提供了新的视角。了解丹参改变肠道菌群、消除HP的医学特性及其作用机制,对改善人类胃肠道保健具有重要意义。本文利用Web of Science、PubMed和谷歌Scholar等数据库,研究丹参与肠道菌群的相互作用及其对HP感染的影响。我们探索了丹参、肠道菌群和HP感染之间的非常规交集,揭示了它们复杂的相互作用和潜在的治疗意义。对这种相互作用的全面了解为开发针对肠道微生物群的新型治疗策略提供了有价值的见解,以减轻hp相关的胃肠道疾病。李世杰,苗建新,王峰,王海燕,马云伟,姜勇,薛旭。丹参成分与幽门螺杆菌感染肠道菌群的相互作用。集成医学[J];打印前Epub。
{"title":"Salvia miltiorrhiza components and gut microbiota interactions in Helicobacter pylori infection","authors":"Shao-jian Li ,&nbsp;Jin-xin Miao ,&nbsp;Fei Wang ,&nbsp;Hao-yu Wang ,&nbsp;Yao-wu Ma ,&nbsp;Ying Jiang ,&nbsp;Xia Xue","doi":"10.1016/j.joim.2025.07.006","DOIUrl":"10.1016/j.joim.2025.07.006","url":null,"abstract":"<div><div><em>Salvia miltiorrhiza</em> (Danshen) is a traditional Chinese herb that is commonly known for its cardiovascular and hepatoprotective benefits. Recent studies have confirmed that Danshen and its bioactive components can influence gut microbial homeostasis, thereby affecting <em>Helicobacter pylori</em> (HP) colonization in the human stomach. HP is a bacterial pathogen associated with various gastrointestinal diseases. Current HP treatments mainly involve antibiotics and proton pump inhibitors. However, their efficacy is strongly compromised by the rapid emergence of antibiotic resistance in HP and genetic heterogeneity among patients. The interaction between Danshen and gut microbial status provides a novel perspective for HP treatment. Understanding the medical properties of Danshen in altering gut microbiota and eliminating HP, as well as the underlying mechanisms, is important for improving human gastrointestinal healthcare. This review investigates the interaction between Danshen and gut microbiota and its impact on HP infection using databases including Web of Science, PubMed, and Google Scholar. We explored the unconventional intersection between Danshen, gut microbiota, and HP infection, shedding light on their intricate interplay and potential therapeutic implications. A comprehensive understanding of this interaction provides valuable insights into developing novel therapeutic strategies that target the gut microbiota to mitigate HP-associated gastrointestinal disorders.</div><div><br>Please cite this article as: Li SJ, Miao JX, Wang F, Wang HY, Ma YW, Jiang Y, Xue X. <em>Salvia miltiorrhiza</em> components and gut microbiota interactions in <em>Helicobacter pylori</em> infection. <em>J Integr Med</em>. 2025; 23(5):462–470.</div></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"23 5","pages":"Pages 462-470"},"PeriodicalIF":4.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144765660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electroacupuncture at ST36 improves gastrointestinal motility disorders by promoting enteric nervous system regeneration through GDNF/Ret signaling in diabetic mice 电针ST36部位通过GDNF/Ret信号通路促进肠道神经系统再生,改善糖尿病小鼠胃肠运动障碍。
IF 4 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 DOI: 10.1016/j.joim.2025.07.007
Jin-lu Guo, Shi Liu, Sheng-jie Ding, Xin Yang, Fan Du

Objective

Diabetes-induced gastrointestinal (GI) motility disorders are increasingly prevalent. Damage to the enteric nervous system (ENS), composed primarily of enteric neurons and glial cells, is an essential mechanism involved in these disorders. Although electroacupuncture (EA) has shown the potential to mitigate enteric neuronal loss, its mechanism is not fully understood. Additionally, the effects of EA on enteric glial cells have not been investigated. Enteric neural precursor cells (ENPCs) contribute to the structural and functional integrity of the ENS, yet whether EA enhances their differentiation into enteric neurons and glial cells remains unexplored. This study investigates whether EA promotes ENS repair through enhancing ENPC-derived neurogenesis and gliogenesis and elucidates the potential molecular mechanisms involved.

Methods

Transgenic mice were used to trace Nestin+/nerve growth factor receptor (Ngfr)+ ENPCs labeled with green fluorescent protein (GFP) in vivo. Mice were randomly divided into four groups: control, diabetes mellitus (DM), DM + sham EA, and DM + EA. The effects of EA on diabetic mice were evaluated by GI motility, ENS structure, and ENPC differentiation. Glial cell line-derived neurotrophic factor (GDNF)/Ret signaling was detected to clarify the underlying molecular mechanisms.

Results

EA alleviated diabetes-induced GI motility disorders, as indicated by reduced whole gut transit time, shortened colonic bead expulsion time, and enhanced smooth muscle contractility. Furthermore, EA attenuated diabetes-induced losses of enteric neurons and glial cells, thereby restoring ENS integrity. Notably, EA reversed the diabetes-induced decrease in ENPCs and significantly increased the absolute number and the proportion of ENPC-derived enteric neurons. However, immunofluorescence analyses revealed no colocalization between EA-induced glial fibrillary acidic protein+ glial cells and GFP-labeled ENPCs. Mechanistically, GDNF/Ret signaling was elevated in intestinal tissues and upregulated in ENPCs in EA-treated diabetic mice.

Conclusion

EA facilitates ENS repair by promoting Nestin+/Ngfr+ ENPC differentiation into enteric neurons via upregulation of GDNF/Ret signaling, and driving enteric gliogenesis from non-Nestin+/Ngfr+ ENPCs. These findings highlight EA’s role in ameliorating diabetes-induced GI dysmotility through ENPC-derived ENS restoration.

Please cite this article as: Guo JL, Liu S, Ding SJ, Yang X, Du F. Electroacupuncture at ST36 improves gastrointestinal motility disorders by promoting enteric nervous system regeneration through GDNF/Ret signaling in diabetic mice. J Integr Med. 2025; 23(5):548–559.
目的:糖尿病引起的胃肠运动障碍越来越普遍。肠神经系统(ENS)主要由肠神经元和神经胶质细胞组成,其损伤是这些疾病的重要机制。虽然电针(EA)已显示出减轻肠道神经元损失的潜力,但其机制尚不完全清楚。此外,EA对肠胶质细胞的影响尚未被研究。肠内神经前体细胞(ENPCs)有助于肠外神经系统的结构和功能完整性,但EA是否能增强它们向肠内神经元和胶质细胞的分化仍未研究。本研究探讨了EA是否通过增强enpc源性神经发生和胶质瘤发生来促进ENS修复,并阐明了可能的分子机制。方法:采用转基因小鼠体内追踪Nestin+/神经生长因子受体(Ngfr)+绿色荧光蛋白(GFP)标记的ENPCs。将小鼠随机分为对照组、糖尿病(DM)组、DM +假EA组和DM + EA组。通过观察EA对糖尿病小鼠胃肠道运动、ENS结构和ENPC分化的影响。检测神经胶质细胞系来源的神经营养因子(GDNF)/Ret信号以阐明潜在的分子机制。结果:EA减轻了糖尿病引起的胃肠道运动障碍,表现为缩短了全肠运输时间,缩短了结肠珠排出时间,增强了平滑肌收缩力。此外,EA减轻了糖尿病引起的肠神经元和胶质细胞的损失,从而恢复了ENS的完整性。值得注意的是,EA逆转了糖尿病诱导的enpc减少,并显著增加了enpc来源的肠神经元的绝对数量和比例。然而,免疫荧光分析显示,ea诱导的胶质纤维酸性蛋白(GFAP)+胶质细胞和GFAP标记的ENPCs之间没有共定位。在机制上,ea治疗的糖尿病小鼠肠组织中GDNF/Ret信号升高,ENPCs中上调。结论:EA通过上调GDNF/Ret信号通路,促进Nestin+/Ngfr+ ENPC向肠神经元分化,促进非Nestin+/Ngfr+ ENPC在肠内形成胶质细胞,从而促进ENS修复。这些发现强调了EA通过enpc衍生的ENS修复在改善糖尿病诱导的GI运动障碍中的作用。郭建林,刘生,丁世杰,杨鑫,杜峰。电针ST36部位通过GDNF/Ret信号通路促进肠道神经系统再生,改善糖尿病小鼠胃肠运动障碍。集成医学[J];打印前Epub。
{"title":"Electroacupuncture at ST36 improves gastrointestinal motility disorders by promoting enteric nervous system regeneration through GDNF/Ret signaling in diabetic mice","authors":"Jin-lu Guo,&nbsp;Shi Liu,&nbsp;Sheng-jie Ding,&nbsp;Xin Yang,&nbsp;Fan Du","doi":"10.1016/j.joim.2025.07.007","DOIUrl":"10.1016/j.joim.2025.07.007","url":null,"abstract":"<div><h3>Objective</h3><div>Diabetes-induced gastrointestinal (GI) motility disorders are increasingly prevalent. Damage to the enteric nervous system (ENS), composed primarily of enteric neurons and glial cells, is an essential mechanism involved in these disorders. Although electroacupuncture (EA) has shown the potential to mitigate enteric neuronal loss, its mechanism is not fully understood. Additionally, the effects of EA on enteric glial cells have not been investigated. Enteric neural precursor cells (ENPCs) contribute to the structural and functional integrity of the ENS, yet whether EA enhances their differentiation into enteric neurons and glial cells remains unexplored. This study investigates whether EA promotes ENS repair through enhancing ENPC-derived neurogenesis and gliogenesis and elucidates the potential molecular mechanisms involved.</div></div><div><h3>Methods</h3><div>Transgenic mice were used to trace Nestin<sup>+</sup>/nerve growth factor receptor (Ngfr)<sup>+</sup> ENPCs labeled with green fluorescent protein (GFP) in vivo. Mice were randomly divided into four groups: control, diabetes mellitus (DM), DM + sham EA, and DM + EA. The effects of EA on diabetic mice were evaluated by GI motility, ENS structure, and ENPC differentiation. Glial cell line-derived neurotrophic factor (GDNF)/Ret signaling was detected to clarify the underlying molecular mechanisms.</div></div><div><h3>Results</h3><div>EA alleviated diabetes-induced GI motility disorders, as indicated by reduced whole gut transit time, shortened colonic bead expulsion time, and enhanced smooth muscle contractility. Furthermore, EA attenuated diabetes-induced losses of enteric neurons and glial cells, thereby restoring ENS integrity. Notably, EA reversed the diabetes-induced decrease in ENPCs and significantly increased the absolute number and the proportion of ENPC-derived enteric neurons. However, immunofluorescence analyses revealed no colocalization between EA-induced glial fibrillary acidic protein<sup>+</sup> glial cells and GFP-labeled ENPCs. Mechanistically, GDNF/Ret signaling was elevated in intestinal tissues and upregulated in ENPCs in EA-treated diabetic mice.</div></div><div><h3>Conclusion</h3><div>EA facilitates ENS repair by promoting Nestin<sup>+</sup>/Ngfr<sup>+</sup> ENPC differentiation into enteric neurons via upregulation of GDNF/Ret signaling, and driving enteric gliogenesis from non-Nestin<sup>+</sup>/Ngfr<sup>+</sup> ENPCs. These findings highlight EA’s role in ameliorating diabetes-induced GI dysmotility through ENPC-derived ENS restoration.</div><div><br>Please cite this article as: Guo JL, Liu S, Ding SJ, Yang X, Du F. Electroacupuncture at ST36 improves gastrointestinal motility disorders by promoting enteric nervous system regeneration through GDNF/Ret signaling in diabetic mice. <em>J Integr Med</em>. 2025; 23(5):548–559.</div></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"23 5","pages":"Pages 548-559"},"PeriodicalIF":4.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144975110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypno-cardiac physiology: Aiming for an organised study of the physiological effects of hypnosis on the cardiovascular system 催眠-心脏生理学:旨在有组织地研究催眠对心血管系统的生理影响。
IF 4 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 DOI: 10.1016/j.joim.2025.07.004
Donato Giuseppe Leo , Simon S. Keller , Riccardo Proietti
Hypnosis is a promising tool in the management of various conditions, such as anxiety and chronic pain. Preliminary studies have shown that hypnosis can directly affect the cardiovascular system, as it increases parasympathetic activation and reduces sympathetic activity. However, the literature related to the effects of hypnosis on cardiovascular health is scarce, mainly due to misconceptions about hypnosis among researchers and medical professionals. This opinion paper examines the role that hypnosis may play in cardiovascular health, highlighting the physiological mechanisms behind it. The evidence suggests that hypnosis has both direct (e.g., changes in the activity of the autonomic nervous system) and indirect (e.g., changes in healthy behaviours) effects on the cardiovascular system; however, further studies are needed to properly define its mechanisms of action and its applicability in improving cardiovascular health. Thus, this opinion paper advocates the adoption of the term “hypno-cardiac physiology” to identify a new research area that gathers experts from neuroscience and cardiovascular science with the joint aim of seeking further understanding of the effects of hypnosis on the cardiovascular system. The adoption of a dedicated term to identify the study of the cardiovascular response to hypnosis will encourage its implementation in cardiovascular health interventions, promoting awareness of its effects among the public and the healthcare community, and promoting the formation of dedicated multidisciplinary research groups and dedicated educational training for healthcare professional interested in its applications.
Please cite this article as: Leo DG, Keller SS, Proietti R. Hypno-cardiac physiology: Aiming for an organised study of the physiological effects of hypnosis on the cardiovascular system. J Integr Med. 2025; 23(5):457–461.
催眠是一种很有前途的治疗各种疾病的工具,比如焦虑和慢性疼痛。初步研究表明,催眠可以直接影响心血管系统,因为它增加副交感神经的激活,减少交感神经的活动。然而,关于催眠对心血管健康影响的文献很少,主要是由于研究人员和医学专业人员对催眠的误解。这篇观点论文探讨了催眠在心血管健康中可能发挥的作用,强调了其背后的生理机制。有证据表明,催眠对心血管系统有直接影响(如自主神经系统活动的改变)和间接影响(如健康行为的改变);然而,其作用机制及其在改善心血管健康方面的适用性还有待进一步研究。因此,本文主张采用“催眠-心脏生理学”一词来确定一个新的研究领域,该领域汇集了神经科学和心血管科学的专家,共同目的是进一步了解催眠对心血管系统的影响。采用一个专门的术语来确定对催眠的心血管反应的研究,将鼓励在心血管健康干预中实施催眠,提高公众和卫生保健社区对催眠效果的认识,并促进成立专门的多学科研究小组,并为对催眠的应用感兴趣的卫生保健专业人员提供专门的教育培训。Leo DG, Keller SS, Proietti R.催眠-心脏生理学:旨在有组织地研究催眠对心血管系统的生理影响。集成医学[J];打印前Epub。
{"title":"Hypno-cardiac physiology: Aiming for an organised study of the physiological effects of hypnosis on the cardiovascular system","authors":"Donato Giuseppe Leo ,&nbsp;Simon S. Keller ,&nbsp;Riccardo Proietti","doi":"10.1016/j.joim.2025.07.004","DOIUrl":"10.1016/j.joim.2025.07.004","url":null,"abstract":"<div><div>Hypnosis is a promising tool in the management of various conditions, such as anxiety and chronic pain. Preliminary studies have shown that hypnosis can directly affect the cardiovascular system, as it increases parasympathetic activation and reduces sympathetic activity. However, the literature related to the effects of hypnosis on cardiovascular health is scarce, mainly due to misconceptions about hypnosis among researchers and medical professionals. This opinion paper examines the role that hypnosis may play in cardiovascular health, highlighting the physiological mechanisms behind it. The evidence suggests that hypnosis has both direct (e.g., changes in the activity of the autonomic nervous system) and indirect (e.g., changes in healthy behaviours) effects on the cardiovascular system; however, further studies are needed to properly define its mechanisms of action and its applicability in improving cardiovascular health. Thus, this opinion paper advocates the adoption of the term “hypno-cardiac physiology” to identify a new research area that gathers experts from neuroscience and cardiovascular science with the joint aim of seeking further understanding of the effects of hypnosis on the cardiovascular system. The adoption of a dedicated term to identify the study of the cardiovascular response to hypnosis will encourage its implementation in cardiovascular health interventions, promoting awareness of its effects among the public and the healthcare community, and promoting the formation of dedicated multidisciplinary research groups and dedicated educational training for healthcare professional interested in its applications.</div><div>Please cite this article as: Leo DG, Keller SS, Proietti R. Hypno-cardiac physiology: Aiming for an organised study of the physiological effects of hypnosis on the cardiovascular system. <em>J Integr Med</em>. 2025; 23(5):457–461.</div></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"23 5","pages":"Pages 457-461"},"PeriodicalIF":4.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144761820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of acupuncture therapies for adult patients with mild and moderate major depressive disorder: A systematic review and meta-analysis 针灸治疗成人轻、中度重度抑郁症的疗效和安全性:一项系统综述和荟萃分析。
IF 4 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 DOI: 10.1016/j.joim.2025.06.008
Hong-jun Kuang , Hui-sheng Yang , Yi-xuan Feng , Han Tang , Qi Fan , Yu-qin Xu , Shuo Cui , Richard Musil , Hedi Luxenburger , Yi-xuan Zhang , Hong Zhao , Yu-qing Zhang
<div><h3>Background</h3><div>Acupuncture therapy provides a complementary and alternative approach to treating major depressive disorder (MDD), but its efficacy and safety have still not been comprehensively assessed. Recently published systematic reviews remain confusing and inconclusive.</div></div><div><h3>Objective</h3><div>This systematic review evaluated the efficacy and safety of acupuncture therapy alone or combined with antidepressants for adult patients with mild and moderate MDD.</div></div><div><h3>Search strategy</h3><div>Chinese Biomedical Literature Database, China National Knowledge Infrastructure Database, Wanfang Database, Chinese Science and Technology Journal Database, PubMed, Embase, and Cochrane Library were searched from their inceptions to March 2025.</div></div><div><h3>Inclusion criteria</h3><div>Randomized controlled trials that compared acupuncture therapy with antidepressants, or acupuncture therapy plus antidepressants with acupuncture therapy or antidepressants for adult patients with mild and moderate MDD were included.</div></div><div><h3>Data extraction and analysis</h3><div>Five reviewers independently extracted data from original literature using a standardized form, and the data were verified by two reviewers to ensure accuracy. Statistical meta-analyses, publication bias analyses, and subgroup analyses were performed by using Review Manager 5.3 software. The Grading of Recommendations Assessment, Development, and Evaluation approach was used to assess the certainty of the evidence.</div></div><div><h3>Results</h3><div>A total of 60 eligible studies including 4675 participants were included. Low-certainty evidence showed that compared with antidepressants, acupuncture therapy (standardized mean difference [SMD] = –0.57; 95% confidence interval [CI] = [–0.87, –0.27]; <em>I<sup>2</sup></em> = 86%; <em>P</em> = 0.006) or acupuncture therapy plus antidepressants (SMD = –1.00; 95% CI = [–1.18, –0.81]; <em>I<sup>2</sup></em> = 77%; <em>P</em> < 0.00001) may reduce the severity of depression at the end of treatment. Low-certainty evidence indicated that compared with acupuncture therapy alone, acupuncture therapy plus antidepressants slightly reduced the severity of depression at the end of treatment (SMD = –0.38; 95% CI = [–0.61, –0.14]; <em>I<sup>2</sup></em> = 18%; <em>P</em> = 0.002). Similar results were also found for acupuncture’s relief of insomnia. The reported adverse effects of acupuncture therapy were mild and transient. For most of the subgroup analyses, acupuncture type, scale type, and the course of treatment did not show a significant relative effect.</div></div><div><h3>Conclusion</h3><div>Acupuncture therapy may provide antidepressant effects and relieve insomnia with mild adverse effects for adult patients with mild and moderate MDD. But the certainty of evidence was very low. More high-quality, well designed, large-scale studies with long-term follow-up are needed in the future.</div><div>Pleas
背景:针刺疗法是治疗重度抑郁症(MDD)的一种补充和替代方法,但其疗效和安全性尚未得到全面评估。最近发表的系统综述仍然令人困惑,也没有定论。目的:本系统评价针刺治疗单独或联合抗抑郁药治疗成人轻中度重度抑郁症的疗效和安全性。检索策略:检索中国生物医学文献数据库、中国国家知识基础数据库、万方数据库、中国科技期刊数据库、PubMed、Embase、Cochrane图书馆自成立至2025年3月。纳入标准:纳入比较针灸治疗与抗抑郁药,或针灸治疗加抗抑郁药与针灸治疗或抗抑郁药治疗轻中度重度抑郁症成人患者的随机对照试验。数据提取与分析:5名审稿人采用标准化表格,独立从原始文献中提取数据,并由2名审稿人对数据进行验证,确保数据的准确性。采用Review Manager 5.3软件进行统计荟萃分析、发表偏倚分析和亚组分析。建议分级评估、发展和评价方法用于评估证据的确定性。结果:共纳入60项符合条件的研究,包括4675名受试者。低确定性证据显示,与抗抑郁药相比,针灸治疗(标准化平均差[SMD] = -0.57;95%置信区间[CI] = [-0.87, -0.27];i2 = 86%;P = 0.006)或针灸治疗加抗抑郁药(SMD = -1.00;95% ci = [-1.18, -0.81];i2 = 77%;p 2 = 18%;p = 0.002)。针灸对失眠的缓解也发现了类似的结果。报道的针灸治疗的不良反应是轻微和短暂的。在大多数亚组分析中,针刺类型、量表类型和治疗过程没有显示出显著的相对影响。结论:针刺疗法对成人轻中度重度抑郁症患者具有抗抑郁、缓解失眠的作用,不良反应轻微。但证据的确定性非常低。未来需要更多高质量、设计良好、大规模的长期随访研究。本文署名:匡海军,杨海生,冯永祥,唐辉,樊强,徐永强,崔思,穆斯瑞,卢森伯格,张永祥,赵宏,张永强。针灸治疗成人轻、中度重度抑郁症的疗效和安全性:一项系统综述和荟萃分析。集成医学[J];打印前Epub。
{"title":"Efficacy and safety of acupuncture therapies for adult patients with mild and moderate major depressive disorder: A systematic review and meta-analysis","authors":"Hong-jun Kuang ,&nbsp;Hui-sheng Yang ,&nbsp;Yi-xuan Feng ,&nbsp;Han Tang ,&nbsp;Qi Fan ,&nbsp;Yu-qin Xu ,&nbsp;Shuo Cui ,&nbsp;Richard Musil ,&nbsp;Hedi Luxenburger ,&nbsp;Yi-xuan Zhang ,&nbsp;Hong Zhao ,&nbsp;Yu-qing Zhang","doi":"10.1016/j.joim.2025.06.008","DOIUrl":"10.1016/j.joim.2025.06.008","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Acupuncture therapy provides a complementary and alternative approach to treating major depressive disorder (MDD), but its efficacy and safety have still not been comprehensively assessed. Recently published systematic reviews remain confusing and inconclusive.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;div&gt;This systematic review evaluated the efficacy and safety of acupuncture therapy alone or combined with antidepressants for adult patients with mild and moderate MDD.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Search strategy&lt;/h3&gt;&lt;div&gt;Chinese Biomedical Literature Database, China National Knowledge Infrastructure Database, Wanfang Database, Chinese Science and Technology Journal Database, PubMed, Embase, and Cochrane Library were searched from their inceptions to March 2025.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Inclusion criteria&lt;/h3&gt;&lt;div&gt;Randomized controlled trials that compared acupuncture therapy with antidepressants, or acupuncture therapy plus antidepressants with acupuncture therapy or antidepressants for adult patients with mild and moderate MDD were included.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Data extraction and analysis&lt;/h3&gt;&lt;div&gt;Five reviewers independently extracted data from original literature using a standardized form, and the data were verified by two reviewers to ensure accuracy. Statistical meta-analyses, publication bias analyses, and subgroup analyses were performed by using Review Manager 5.3 software. The Grading of Recommendations Assessment, Development, and Evaluation approach was used to assess the certainty of the evidence.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;A total of 60 eligible studies including 4675 participants were included. Low-certainty evidence showed that compared with antidepressants, acupuncture therapy (standardized mean difference [SMD] = –0.57; 95% confidence interval [CI] = [–0.87, –0.27]; &lt;em&gt;I&lt;sup&gt;2&lt;/sup&gt;&lt;/em&gt; = 86%; &lt;em&gt;P&lt;/em&gt; = 0.006) or acupuncture therapy plus antidepressants (SMD = –1.00; 95% CI = [–1.18, –0.81]; &lt;em&gt;I&lt;sup&gt;2&lt;/sup&gt;&lt;/em&gt; = 77%; &lt;em&gt;P&lt;/em&gt; &lt; 0.00001) may reduce the severity of depression at the end of treatment. Low-certainty evidence indicated that compared with acupuncture therapy alone, acupuncture therapy plus antidepressants slightly reduced the severity of depression at the end of treatment (SMD = –0.38; 95% CI = [–0.61, –0.14]; &lt;em&gt;I&lt;sup&gt;2&lt;/sup&gt;&lt;/em&gt; = 18%; &lt;em&gt;P&lt;/em&gt; = 0.002). Similar results were also found for acupuncture’s relief of insomnia. The reported adverse effects of acupuncture therapy were mild and transient. For most of the subgroup analyses, acupuncture type, scale type, and the course of treatment did not show a significant relative effect.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;Acupuncture therapy may provide antidepressant effects and relieve insomnia with mild adverse effects for adult patients with mild and moderate MDD. But the certainty of evidence was very low. More high-quality, well designed, large-scale studies with long-term follow-up are needed in the future.&lt;/div&gt;&lt;div&gt;Pleas","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"23 5","pages":"Pages 471-491"},"PeriodicalIF":4.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144761871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Baicalein attenuates lipopolysaccharide-induced myocardial injury by inhibiting ferroptosis via miR-299b-5p/HIF1-α pathway 黄芩素通过miR-299b-5p/HIF1-α途径抑制铁凋亡,减轻脂多糖诱导的心肌损伤。
IF 4 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 DOI: 10.1016/j.joim.2025.07.001
Wen-yan Zhou , Jian-kui Du , Hong-hong Liu , Lei Deng , Kai Ma , Jian Xiao , Sheng Zhang , Chang-nan Wang

Objective

Baicalein has been reported to have wide therapeutic effects that act through its anti-inflammatory activity. This study examines the effect and mechanism of baicalein on sepsis-induced cardiomyopathy (SIC).

Methods

A thorough screening of a small library of natural products, comprising 100 diverse compounds, was conducted to identify the most effective drug against lipopolysaccharide (LPS)-treated H9C2 cardiomyocytes. The core target proteins and their associated signaling pathways involved in baicalein’s efficacy against LPS-induced myocardial injury were predicted by network pharmacology.

Results

Baicalein was identified as the most potent protective agent in LPS-exposed H9C2 cardiomyocytes. It exhibited a dose-dependent inhibitory effect on cell injury and inflammation. In the LPS-induced septic mouse model, baicalein demonstrated a significant capacity to mitigate LPS-triggered myocardial deficits, inflammatory responses, and ferroptosis. Network pharmacological analysis and experimental confirmation suggested that hypoxia-inducible factor 1 subunit α (HIF1-α) is likely to be the crucial factor in mediating the impact of baicalein against LPS-induced myocardial ferroptosis and injury. By combining microRNA (miRNA) screening in LPS-treated myocardium with miRNA prediction targeting HIF1-α, we found that miR-299b-5p may serve as a regulator of HIF1-α. The reduction in miR-299b-5p levels in LPS-treated myocardium, compared to the control group, was reversed by baicalein treatment. The reverse transcription quantitative polymerase chain reaction, Western blotting, and dual-luciferase reporter gene analyses together identified HIF1-α as the target of miR-299b-5p in cardiomyocytes.

Conclusion

Baicalein mitigates SIC at the miRNA level, suggesting the therapeutic potential of it in treating SIC through the regulation of miR-299b-5p/HIF1-α/ferroptosis pathway.

Please cite this article as: Zhou WY, Du JK, Liu HH, Deng L, Ma K, Xiao J, Zhang S, Wang CN. Baicalein attenuates lipopolysaccharide-induced myocardial injury by inhibiting ferroptosis via miR-299b-5p/HIF1-α pathway. J Integr Med. 2025; 23(5):560–575.
目的:黄芩素具有广泛的抗炎治疗作用。本研究探讨黄芩素对败血症性心肌病(SIC)的作用及其机制。方法:对天然产物的一个小文库进行彻底筛选,包括100种不同的化合物,以确定对脂多糖(LPS)处理的H9C2心肌细胞最有效的药物。应用网络药理学方法预测黄芩素抗lps诱导心肌损伤的核心靶蛋白及其相关信号通路。结果:黄芩苷对lps暴露的H9C2心肌细胞的保护作用最强。对细胞损伤和炎症表现出剂量依赖性的抑制作用。在lps诱导的脓毒症小鼠模型中,黄芩素显示出显著的减轻lps引发的心肌缺陷、炎症反应和铁下垂的能力。网络药理分析和实验证实,缺氧诱导因子1亚单位α (HIF1-α)可能是黄芩素介导lps诱导的心肌铁下垂和损伤的关键因素。通过将lps处理心肌中的microRNA (miRNA)筛选与靶向HIF1-α的miRNA预测相结合,我们发现miR-299b-5p可能是HIF1-α的调节因子。与对照组相比,lps处理心肌中miR-299b-5p水平的降低被黄芩素治疗逆转。逆转录定量聚合酶链反应、Western blotting和双荧光素酶报告基因分析共同确定HIF1-α是心肌细胞中miR-299b-5p的靶标。结论:黄芩素在miRNA水平上缓解SIC,提示其通过调控miR-299b-5p/HIF1-α/铁ptosis通路治疗SIC的治疗潜力。本文署名:周伟,杜建军,刘海红,邓磊,马凯,肖军,张生,王纯。黄芩素通过miR-299b-5p/HIF1-α途径抑制铁凋亡,减轻脂多糖诱导的心肌损伤。集成医学[J];打印前Epub。
{"title":"Baicalein attenuates lipopolysaccharide-induced myocardial injury by inhibiting ferroptosis via miR-299b-5p/HIF1-α pathway","authors":"Wen-yan Zhou ,&nbsp;Jian-kui Du ,&nbsp;Hong-hong Liu ,&nbsp;Lei Deng ,&nbsp;Kai Ma ,&nbsp;Jian Xiao ,&nbsp;Sheng Zhang ,&nbsp;Chang-nan Wang","doi":"10.1016/j.joim.2025.07.001","DOIUrl":"10.1016/j.joim.2025.07.001","url":null,"abstract":"<div><h3>Objective</h3><div>Baicalein has been reported to have wide therapeutic effects that act through its anti-inflammatory activity. This study examines the effect and mechanism of baicalein on sepsis-induced cardiomyopathy (SIC).</div></div><div><h3>Methods</h3><div>A thorough screening of a small library of natural products, comprising 100 diverse compounds, was conducted to identify the most effective drug against lipopolysaccharide (LPS)-treated H9C2 cardiomyocytes. The core target proteins and their associated signaling pathways involved in baicalein’s efficacy against LPS-induced myocardial injury were predicted by network pharmacology.</div></div><div><h3>Results</h3><div>Baicalein was identified as the most potent protective agent in LPS-exposed H9C2 cardiomyocytes. It exhibited a dose-dependent inhibitory effect on cell injury and inflammation. In the LPS-induced septic mouse model, baicalein demonstrated a significant capacity to mitigate LPS-triggered myocardial deficits, inflammatory responses, and ferroptosis. Network pharmacological analysis and experimental confirmation suggested that hypoxia-inducible factor 1 subunit α (HIF1-α) is likely to be the crucial factor in mediating the impact of baicalein against LPS-induced myocardial ferroptosis and injury. By combining microRNA (miRNA) screening in LPS-treated myocardium with miRNA prediction targeting <em>HIF1-α</em>, we found that miR-299b-5p may serve as a regulator of HIF1-α. The reduction in miR-299b-5p levels in LPS-treated myocardium, compared to the control group, was reversed by baicalein treatment. The reverse transcription quantitative polymerase chain reaction, Western blotting, and dual-luciferase reporter gene analyses together identified <em>HIF1-α</em> as the target of miR-299b-5p in cardiomyocytes.</div></div><div><h3>Conclusion</h3><div>Baicalein mitigates SIC at the miRNA level, suggesting the therapeutic potential of it in treating SIC through the regulation of miR-299b-5p/HIF1-α/ferroptosis pathway.</div><div><br> Please cite this article as: Zhou WY, Du JK, Liu HH, Deng L, Ma K, Xiao J, Zhang S, Wang CN. Baicalein attenuates lipopolysaccharide-induced myocardial injury by inhibiting ferroptosis via miR-299b-5p/HIF1-α pathway. <em>J Integr Med</em>. 2025; 23(5):560–575.</div></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"23 5","pages":"Pages 560-575"},"PeriodicalIF":4.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144692022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between acupuncture and live birth rates after fresh embryo transfer: A cohort study based on different propensity score methods 针刺与新鲜胚胎移植后活产率的关系:基于不同倾向评分方法的队列研究。
IF 4 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 DOI: 10.1016/j.joim.2025.06.007
Xiao-yan Zheng , Zi-yi Jiang , Yi-ting Li , Chao-liang Li , Hao Zhu , Zheng Yu , Si-yi Yu , Li-li Yang , Song-yuan Tang , Xing-yu Lü , Fan-rong Liang , Jie Yang

Objective

To explore the association between acupuncture during controlled ovarian hyperstimulation (COH) and the live birth rate (LBR) using different propensity score methods.

Methods

In this retrospective cohort study, eligible women who underwent a COH were divided into acupuncture and non-acupuncture groups. The primary outcome was LBR, as determined by propensity score matching (PSM). LBR was defined as the delivery of one or more living infants that reached a gestational age over 28 weeks after embryo transfer. The propensity score model encompassed 16 confounding variables. To validate the results, sensitivity analyses were conducted using three additional propensity score methods: propensity score adjustment, inverse probability weighting (IPW), and IPW with a “doubly robust” estimator.

Results

The primary cohort encompassed 9751 patients (1830 [18.76%] in the acupuncture group and 7921 [81.23%] in the non-acupuncture group). Following 1:1 PSM, a higher LBR was found in the acupuncture cohort (41.4% [755/1824] vs 36.4% [664/1824], with an odds ratio of 1.23 [95% confidence interval, 1.08–1.41]). Three additional propensity score methods produced essentially similar results. The risk of serious adverse events did not significantly differ between the two groups.

Conclusion

This retrospective study revealed an association between acupuncture and an increased LBR among patients undergoing COH, and that acupuncture is a safe and valuable treatment option.
Please cite this article as: Zheng XY, Jiang ZY, Li YT, Li CL, Zhu H, Yu Z, Yu SY, Yang LL, Tang SY, Lü XY, Liang FR, Yang J. Association between acupuncture and live birth rates after fresh embryo transfer: A cohort study based on different propensity score methods. J Integr Med. 2025; 23(5):528–536.
目的:采用不同倾向评分法探讨针刺控制性卵巢过度刺激(COH)与活产率(LBR)的关系。方法:在这项回顾性队列研究中,将接受COH的符合条件的妇女分为针灸组和非针灸组。主要结局是LBR,由倾向评分匹配(PSM)决定。LBR被定义为胚胎移植后一个或多个胎龄超过28周的活婴的分娩。倾向得分模型包含16个混杂变量。为了验证结果,使用另外三种倾向评分方法进行敏感性分析:倾向评分调整、逆概率加权(IPW)和带有“双鲁棒”估计器的IPW。结果:主要队列纳入9751例患者,其中针灸组1830例(18.76%),非针灸组7921例(81.23%)。在1:1 PSM后,针灸组的LBR更高(41.4% [755/1824]vs 36.4%[664/1824],比值比为1.23[95%可信区间,1.08-1.41])。另外三种倾向评分方法产生了本质上相似的结果。两组患者发生严重不良事件的风险无显著差异。结论:这项回顾性研究揭示了针灸与COH患者LBR增加之间的关联,并且针灸是一种安全且有价值的治疗选择。郑晓燕,蒋志强,李玉婷,李春林,朱华,于志,于思思,杨丽丽,唐思义,Lü杨晓燕,梁福荣,杨杰。针刺与新鲜胚胎移植后活产率的关系:基于不同倾向评分方法的队列研究。集成医学[J];打印前Epub。
{"title":"Association between acupuncture and live birth rates after fresh embryo transfer: A cohort study based on different propensity score methods","authors":"Xiao-yan Zheng ,&nbsp;Zi-yi Jiang ,&nbsp;Yi-ting Li ,&nbsp;Chao-liang Li ,&nbsp;Hao Zhu ,&nbsp;Zheng Yu ,&nbsp;Si-yi Yu ,&nbsp;Li-li Yang ,&nbsp;Song-yuan Tang ,&nbsp;Xing-yu Lü ,&nbsp;Fan-rong Liang ,&nbsp;Jie Yang","doi":"10.1016/j.joim.2025.06.007","DOIUrl":"10.1016/j.joim.2025.06.007","url":null,"abstract":"<div><h3>Objective</h3><div>To explore the association between acupuncture during controlled ovarian hyperstimulation (COH) and the live birth rate (LBR) using different propensity score methods.</div></div><div><h3>Methods</h3><div>In this retrospective cohort study, eligible women who underwent a COH were divided into acupuncture and non-acupuncture groups. The primary outcome was LBR, as determined by propensity score matching (PSM). LBR was defined as the delivery of one or more living infants that reached a gestational age over 28 weeks after embryo transfer. The propensity score model encompassed 16 confounding variables. To validate the results, sensitivity analyses were conducted using three additional propensity score methods: propensity score adjustment, inverse probability weighting (IPW), and IPW with a “doubly robust” estimator.</div></div><div><h3>Results</h3><div>The primary cohort encompassed 9751 patients (1830 [18.76%] in the acupuncture group and 7921 [81.23%] in the non-acupuncture group). Following 1:1 PSM, a higher LBR was found in the acupuncture cohort (41.4% [755/1824] <em>vs</em> 36.4% [664/1824], with an odds ratio of 1.23 [95% confidence interval, 1.08–1.41]). Three additional propensity score methods produced essentially similar results. The risk of serious adverse events did not significantly differ between the two groups.</div></div><div><h3>Conclusion</h3><div>This retrospective study revealed an association between acupuncture and an increased LBR among patients undergoing COH, and that acupuncture is a safe and valuable treatment option.</div><div>Please cite this article as: Zheng XY, Jiang ZY, Li YT, Li CL, Zhu H, Yu Z, Yu SY, Yang LL, Tang SY, Lü XY, Liang FR, Yang J. Association between acupuncture and live birth rates after fresh embryo transfer: A cohort study based on different propensity score methods. <em>J Integr Med</em>. 2025; 23(5):528–536.</div></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"23 5","pages":"Pages 528-536"},"PeriodicalIF":4.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144610023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Huachansu injection enhances anti-colorectal cancer efficacy of irinotecan and alleviates its induced intestinal toxicity through upregulating UGT1A1-OATP1B3 expression in vitro and in vivo 花肠素注射液通过上调体外和体内UGT1A1-OATP1B3表达,增强伊立替康抗结直肠癌的疗效,减轻其诱导的肠道毒性。
IF 4 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 DOI: 10.1016/j.joim.2025.06.006
Bo Jiang , Zhao-yang Meng , Yu-jie Hu , Jun-jun Chen , Ling Zong , Ling-yan Xu , Xiang-qi Zhang , Jing-xian Zhang , Yong-long Han

Objective

Huachansu injection (HCSI), a promising anti-cancer Chinese medicine injection, has been reported to have the potential for reducing the toxicity of chemotherapy and improving the quality of life for colorectal cancer (CRC) patients. The objective of this study is to explore the synergistic and detoxifying effects of HCSI when used in combination with irinotecan (CPT-11).

Methods

To investigate the effect of HCSI on anti-CRC efficacy and intestinal toxicity of CPT-11, we measured changes in the biological behavior of LoVo cells in vitro, and anti-tumor effects in LoVo cell xenograft nude mice models in vivo. Meanwhile, the effect of HCSI on intestinal toxicity and the uridine diphosphate-glucuronosyltransferase 1A1 (UGT1A1) expression was investigated in the CPT-11-induced colitis mouse model. Subsequently, we measured the effect of HCSI and its 13 constituent bufadienolides on the expression of UGT1A1 and organic anion transporting polypeptides 1B3 (OATP1B3) in HepG2 cells.

Results

The combination index (CI) results showed that the combination of HCSI and CPT-11 exhibited a synergistic effect (CI < 1), which significantly suppressing the LoVo cell migration, enhancing G2/M and S phase arrest, and inhibiting tumor growth in vivo. Additionally, the damage to intestinal tissues was attenuated by HCSI in CPT-11-induced colitis model, while the increased expression of UGT1A1 in HepG2 cells and in mouse was observed.

Conclusion

The co-therapy with HCSI alleviated the intestinal toxicity induced by CPT-11 and exerted an enhanced anti-CRC effect. The detoxifying mechanism may be related to the increased expression of UGT1A1 and OATP1B3 by HCSI and its bufadienolides components. The findings of this study may serve as a theoretical insights and strategies to improve CRC patient outcomes. Please cite this article as: Jiang B, Meng ZY, Hu YJ, Chen JJ, Zong L, Xu LY, Zhang XQ, Zhang JX, Han YL. Huachansu injection enhances anti-colorectal cancer efficacy of irinotecan and alleviates its induced intestinal toxicity through upregulating UGT1A1-OATP1B3 expression in vitro and in vivo. J Integr Med. 2025; 23(5):576–590.
目的:花脓素注射液(HCSI)是一种很有前景的抗癌中药注射剂,有可能降低结直肠癌(CRC)患者的化疗毒性,提高患者的生活质量。本研究的目的是探讨HCSI与伊立替康(CPT-11)联合使用时的协同和解毒作用。方法:为了研究HCSI对CPT-11抗crc疗效和肠道毒性的影响,我们在体外检测了LoVo细胞生物学行为的变化,并在体内检测了LoVo细胞异种移植裸鼠模型的抗肿瘤作用。同时,在cpt -11诱导的结肠炎小鼠模型中,研究HCSI对肠道毒性和尿苷二磷酸-葡萄糖醛酸糖基转移酶1A1 (UGT1A1)表达的影响。随后,我们测量了HCSI及其13种成分蟾二烯内酯对HepG2细胞中UGT1A1和有机阴离子转运多肽1B3 (OATP1B3)表达的影响。结果:联合指数(CI)结果显示HCSI与CPT-11联合治疗具有协同作用(CI)结论:HCSI联合治疗可减轻CPT-11引起的肠道毒性,增强抗crc作用。解毒机制可能与HCSI及其蟾二烯内酯成分增加UGT1A1和OATP1B3的表达有关。本研究结果可作为改善结直肠癌患者预后的理论见解和策略。姜波,bbbzy,胡玉军,陈建军,宗丽,徐丽丽,张晓青,张建新,韩玉玲。花肠素注射液通过上调伊立替康体内外UGT1A1-OATP1B3的表达,增强伊立替康抗结直肠癌的疗效,减轻其诱导的肠道毒性。集成医学[J];打印前Epub。
{"title":"Huachansu injection enhances anti-colorectal cancer efficacy of irinotecan and alleviates its induced intestinal toxicity through upregulating UGT1A1-OATP1B3 expression in vitro and in vivo","authors":"Bo Jiang ,&nbsp;Zhao-yang Meng ,&nbsp;Yu-jie Hu ,&nbsp;Jun-jun Chen ,&nbsp;Ling Zong ,&nbsp;Ling-yan Xu ,&nbsp;Xiang-qi Zhang ,&nbsp;Jing-xian Zhang ,&nbsp;Yong-long Han","doi":"10.1016/j.joim.2025.06.006","DOIUrl":"10.1016/j.joim.2025.06.006","url":null,"abstract":"<div><h3>Objective</h3><div><span>Huachansu injection (HCSI), a promising anti-cancer Chinese medicine injection, has been reported to have the potential for reducing the toxicity of chemotherapy and improving the quality of life for </span>colorectal cancer<span> (CRC) patients. The objective of this study is to explore the synergistic and detoxifying effects of HCSI when used in combination with irinotecan (CPT-11).</span></div></div><div><h3>Methods</h3><div><span><span>To investigate the effect of HCSI on anti-CRC efficacy and intestinal toxicity of CPT-11, we measured changes in the biological behavior of LoVo cells in vitro, and anti-tumor effects in LoVo cell xenograft </span>nude mice<span> models in vivo. Meanwhile, the effect of HCSI on intestinal toxicity and the uridine diphosphate-glucuronosyltransferase 1A1 (UGT1A1) expression was investigated in the CPT-11-induced colitis mouse model. Subsequently, we measured the effect of HCSI and its 13 constituent </span></span>bufadienolides<span> on the expression of UGT1A1 and organic anion transporting polypeptides 1B3 (OATP1B3) in HepG2 cells.</span></div></div><div><h3>Results</h3><div>The combination index (CI) results showed that the combination of HCSI and CPT-11 exhibited a synergistic effect (CI &lt; 1), which significantly suppressing the LoVo cell migration, enhancing G2/M and S phase arrest, and inhibiting tumor growth in vivo. Additionally, the damage to intestinal tissues was attenuated by HCSI in CPT-11-induced colitis model, while the increased expression of UGT1A1 in HepG2 cells and in mouse was observed.</div></div><div><h3>Conclusion</h3><div>The co-therapy with HCSI alleviated the intestinal toxicity induced by CPT-11 and exerted an enhanced anti-CRC effect. The detoxifying mechanism may be related to the increased expression of UGT1A1 and OATP1B3 by HCSI and its bufadienolides components. The findings of this study may serve as a theoretical insights and strategies to improve CRC patient outcomes. Please cite this article as: Jiang B, Meng ZY, Hu YJ, Chen JJ, Zong L, Xu LY, Zhang XQ, Zhang JX, Han YL. Huachansu injection enhances anti-colorectal cancer efficacy of irinotecan and alleviates its induced intestinal toxicity through upregulating UGT1A1-OATP1B3 expression in vitro and in vivo. <em>J Integr Med</em>. 2025; 23(5):576–590.</div></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"23 5","pages":"Pages 576-590"},"PeriodicalIF":4.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144576636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electroacupuncture for hot flashes in early menopause: A randomized sham-controlled trial 电针治疗更年期早期潮热:一项随机假对照试验。
IF 4 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 DOI: 10.1016/j.joim.2025.07.008
Hui-xian Wang , Xin-tong Yu , Jing Hu , Jin-jia Chen , Yu-ting Mei , Yun-fei Chen
<div><h3>Background</h3><div>Electroacupuncture (EA) may affect the severity of hot flashes (HFs) associated with natural menopause and provide additional benefits for postmenopausal women. However, the evidence for its effectiveness in the management of early postmenopausal HFs remains inadequately understood.</div></div><div><h3>Objective</h3><div>We designed this trial to assess the efficacy and safety of EA for relieving early postmenopausal HFs.</div></div><div><h3>Design, setting, participants and interventions</h3><div>This randomized sham-controlled trial involved 72 women with HFs. The participants were divided equally into the intervention and control groups. The intervention group was treated with EA, while the control group was treated with sham acupuncture. The main acupoints used were Hegu (LI4), Guanyuan (RN4), Sanyinjiao (SP6), Taixi (KI3), Fuliu (KI7) and Shenshu (BL23). All participants received 18 treatment sessions, distributed across a 6-week period. The treatment was administered on three occasions per week, adhering to a fixed weekday schedule (Monday, Wednesday, Friday or Tuesday, Thursday, Saturday) with a minimum interval of one day between sessions. Each patient received a 12-week follow-up.</div></div><div><h3>Main outcome measures</h3><div>The HF score was the primary outcome. Participants documented the frequency and severity of HFs in a 7-day symptom diary, which provided data for calculating the HF score. Secondary outcomes were the Menopause Rating Scale (MRS), Menopause-Specific Quality of Life Questionnaire (MENQOL), Pittsburgh Sleep Quality Index (PSQI) and Traditional Chinese Medicine Syndrome Score Scale (TCMSSS), as well as estradiol (E<sub>2</sub>), luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels.</div></div><div><h3>Results</h3><div>Both groups demonstrated significant reductions in HF scores after the treatment and during the follow-up (<em>P</em> < 0.001). Immediately after completion of the 6-week treatment cycle and at 12 weeks post-intervention, the HF scores were similar in both groups. At week 6, the intervention group showed significantly greater improvements in MRS, MENQOL (vasomotor, psychosocial, and physical), PSQI and TCMSSS scores (<em>P</em> < 0.05). The improvements in the MENQOL (vasomotor, and psychosocial) and PSQI total scores persisted through the follow-up (<em>P</em> < 0.05). However, the results showed no significant inter- or intragroup differences in sexual scores on the MENQOL (<em>P</em> > 0.05). EA did not significantly decrease E<sub>2</sub>, LH or FSH levels compared to placebo. The incidence of adverse events was similar in both groups.</div></div><div><h3>Conclusion</h3><div>EA does not significantly improve HFs in early postmenopausal patients. However, it enhances the quality of sleep and decreases menopausal symptoms across vasomotor, psychosocial and physical domains.</div><div><em>Trial registration</em>: Chinese Clinical Trial Regist
背景:电针(EA)可能影响与自然绝经相关的潮热(HFs)的严重程度,并为绝经后妇女提供额外的益处。然而,其在早期绝经后HFs管理中的有效性的证据仍不充分了解。目的:我们设计了这项试验,以评估EA缓解绝经后早期hf的有效性和安全性。设计、设置、参与者和干预措施:这项随机的假对照试验涉及72名患有hf的女性。参与者被平均分为干预组和对照组。干预组采用电针治疗,对照组采用假针刺治疗。主要穴位为合谷穴(LI4)、官园穴(RN4)、三阴角穴(SP6)、太溪穴(KI3)、扶柳穴(KI7)、肾俞穴(BL23)。所有参与者接受了18次治疗,分布在6周的时间内。治疗每周进行三次,坚持固定的工作日时间表(周一,周三,周五或周二,周四,周六),每次治疗之间至少间隔一天。每位患者接受为期12周的随访。主要观察指标:HF评分为主要观察指标。参与者在7天的症状日记中记录HF的频率和严重程度,这为计算HF评分提供了数据。次要观察指标为绝经评定量表(MRS)、绝经期生活质量问卷(MENQOL)、匹兹堡睡眠质量指数(PSQI)和中医证候评分量表(TCMSSS),以及雌二醇(E2)、黄体生成素(LH)和促卵泡激素(FSH)水平。结果:两组治疗后及随访期间HF评分均有显著降低(P < 0.05)。与安慰剂相比,EA没有显著降低E2、LH或FSH水平。两组不良事件发生率相似。结论:EA对早期绝经后患者的HFs无显著改善作用。然而,它提高了睡眠质量,减少了血管舒缩、心理社会和身体领域的更年期症状。试验注册:中国临床试验注册中心(http://www.chictr.org.cn);试用号:ChiCTR2300072002。这篇文章的署名是:王红霞,于小涛,胡洁,陈静杰,梅玉婷,陈玉峰。电针治疗更年期早期潮热:一项随机假对照试验。集成医学[J];打印前Epub。
{"title":"Electroacupuncture for hot flashes in early menopause: A randomized sham-controlled trial","authors":"Hui-xian Wang ,&nbsp;Xin-tong Yu ,&nbsp;Jing Hu ,&nbsp;Jin-jia Chen ,&nbsp;Yu-ting Mei ,&nbsp;Yun-fei Chen","doi":"10.1016/j.joim.2025.07.008","DOIUrl":"10.1016/j.joim.2025.07.008","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Electroacupuncture (EA) may affect the severity of hot flashes (HFs) associated with natural menopause and provide additional benefits for postmenopausal women. However, the evidence for its effectiveness in the management of early postmenopausal HFs remains inadequately understood.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;div&gt;We designed this trial to assess the efficacy and safety of EA for relieving early postmenopausal HFs.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Design, setting, participants and interventions&lt;/h3&gt;&lt;div&gt;This randomized sham-controlled trial involved 72 women with HFs. The participants were divided equally into the intervention and control groups. The intervention group was treated with EA, while the control group was treated with sham acupuncture. The main acupoints used were Hegu (LI4), Guanyuan (RN4), Sanyinjiao (SP6), Taixi (KI3), Fuliu (KI7) and Shenshu (BL23). All participants received 18 treatment sessions, distributed across a 6-week period. The treatment was administered on three occasions per week, adhering to a fixed weekday schedule (Monday, Wednesday, Friday or Tuesday, Thursday, Saturday) with a minimum interval of one day between sessions. Each patient received a 12-week follow-up.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Main outcome measures&lt;/h3&gt;&lt;div&gt;The HF score was the primary outcome. Participants documented the frequency and severity of HFs in a 7-day symptom diary, which provided data for calculating the HF score. Secondary outcomes were the Menopause Rating Scale (MRS), Menopause-Specific Quality of Life Questionnaire (MENQOL), Pittsburgh Sleep Quality Index (PSQI) and Traditional Chinese Medicine Syndrome Score Scale (TCMSSS), as well as estradiol (E&lt;sub&gt;2&lt;/sub&gt;), luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Both groups demonstrated significant reductions in HF scores after the treatment and during the follow-up (&lt;em&gt;P&lt;/em&gt; &lt; 0.001). Immediately after completion of the 6-week treatment cycle and at 12 weeks post-intervention, the HF scores were similar in both groups. At week 6, the intervention group showed significantly greater improvements in MRS, MENQOL (vasomotor, psychosocial, and physical), PSQI and TCMSSS scores (&lt;em&gt;P&lt;/em&gt; &lt; 0.05). The improvements in the MENQOL (vasomotor, and psychosocial) and PSQI total scores persisted through the follow-up (&lt;em&gt;P&lt;/em&gt; &lt; 0.05). However, the results showed no significant inter- or intragroup differences in sexual scores on the MENQOL (&lt;em&gt;P&lt;/em&gt; &gt; 0.05). EA did not significantly decrease E&lt;sub&gt;2&lt;/sub&gt;, LH or FSH levels compared to placebo. The incidence of adverse events was similar in both groups.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;EA does not significantly improve HFs in early postmenopausal patients. However, it enhances the quality of sleep and decreases menopausal symptoms across vasomotor, psychosocial and physical domains.&lt;/div&gt;&lt;div&gt;&lt;em&gt;Trial registration&lt;/em&gt;: Chinese Clinical Trial Regist","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"23 5","pages":"Pages 519-527"},"PeriodicalIF":4.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144975091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological quality of systematic reviews on orally administered Chinese herbal medicine published in Chinese between 2021 and 2022: A cross-sectional study 2021年至2022年间发表的口服中草药系统评价的方法学质量:一项横断面研究
IF 4 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 DOI: 10.1016/j.joim.2025.07.005
Yue Jiang , Claire Chenwen Zhong , Betty Huan Wang , Shan-shan Xu , Fai Fai Ho , Ming Hong Kwong , Leonard Ho , Joson Hao-Shen Zhou , K.C. Lam , Jian-ping Liu , Bao-ting Zhang , Vincent Chi Ho Chung

Objective

This cross-sectional study assessed the methodological quality of systematic reviews (SRs) of Chinese herbal medicine (CHM) published in Chinese between Jan 2021 and Sep 2022.

Methods

Chinese language CHM SRs were identified through literature searches across 3 international and 4 Chinese databases. Methodological quality was appraised using A MeaSurement Tool to Assess systematic Reviews 2. Logistic regressions were used to explore associations between bibliographical characteristics and quality.

Results

Analyses of methodological quality found that among the 213 sampled SRs, 69.5% were of critically low quality, 30.5% were of low quality, and none achieved high or moderate quality. Common shortcomings included the failure to identify the studies excluded from the analysis, failure to disclose funding sources, and limited evaluation of the potential impact of bias on conclusions. Logistic regressions revealed that SRs led by corresponding authors affiliated with universities or academic institutions tended to be of lower quality than SRs led by authors affiliated with hospitals or clinical facilities.

Conclusion

Recent Chinese language CHM SRs exhibited limited methodological quality, making them unlikely to support the development of clinical practice guidelines. Urgent initiatives are needed to enhance training for researchers, peer-reviewers and editors involved in the preparation and publication of SRs. Adoption of Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guidelines in Chinese language journals is crucial to improve the relevance of SRs for Chinese medicine development. Addressing deficiencies in methodology and reporting is essential for promoting evidence-based practices and informed clinical decisions in Chinese medicine.

Please cite this article as: Jiang Y, Zhong CC, Wang BH, Xu SS, Ho FF, Kwong MH, Ho L, Zhou JHS, Lam KC, Liu JP, Zhang BT, Chung VCH. Methodological quality of systematic reviews on orally administered Chinese herbal medicine published in Chinese between 2021 and 2022: A cross-sectional study. J Integr Med. 2025; 23(5):492–501.
目的:本横断面研究评估了在2021年1月至2022年9月间发表的中文中草药系统评价(SRs)的方法学质量。方法:通过3个国际数据库和4个国内数据库的文献检索,对汉文中药特定剂进行鉴定。使用测量工具评估系统评价2对方法学质量进行评价。使用逻辑回归来探讨书目特征与质量之间的关系。结果:方法质量分析发现,在213份抽样的SRs中,69.5%为极低质量,30.5%为低质量,没有一个达到高质量或中等质量。常见的缺点包括未能确定被排除在分析之外的研究,未能披露资金来源,以及对偏见对结论的潜在影响的评估有限。Logistic回归分析显示,隶属于大学或学术机构的通讯作者撰写的论文质量往往低于隶属于医院或临床机构的通讯作者撰写的论文质量。结论:近期的中文CHM SRs显示出有限的方法学质量,使其不太可能支持临床实践指南的发展。需要采取紧急行动,加强对参与编写和出版社会报告的研究人员、同行审稿人和编辑的培训。在中文期刊的系统评价和荟萃分析报告指南中采用首选报告项目对于提高SRs与中医药发展的相关性至关重要。解决方法和报告方面的缺陷对于促进中医循证实践和知情临床决策至关重要。蒋勇,钟国伟,王宝宝,徐顺生,何福荣,邝明辉,何磊,周建生,林建奎,刘金平,钟伟昌,张宝成。2021 - 2022年发表的口服中药系统评价的方法学质量:横断面研究。集成医学[J];打印前Epub。
{"title":"Methodological quality of systematic reviews on orally administered Chinese herbal medicine published in Chinese between 2021 and 2022: A cross-sectional study","authors":"Yue Jiang ,&nbsp;Claire Chenwen Zhong ,&nbsp;Betty Huan Wang ,&nbsp;Shan-shan Xu ,&nbsp;Fai Fai Ho ,&nbsp;Ming Hong Kwong ,&nbsp;Leonard Ho ,&nbsp;Joson Hao-Shen Zhou ,&nbsp;K.C. Lam ,&nbsp;Jian-ping Liu ,&nbsp;Bao-ting Zhang ,&nbsp;Vincent Chi Ho Chung","doi":"10.1016/j.joim.2025.07.005","DOIUrl":"10.1016/j.joim.2025.07.005","url":null,"abstract":"<div><h3>Objective</h3><div>This cross-sectional study assessed the methodological quality of systematic reviews (SRs) of Chinese herbal medicine (CHM) published in Chinese between Jan 2021 and Sep 2022.</div></div><div><h3>Methods</h3><div>Chinese language CHM SRs were identified through literature searches across 3 international and 4 Chinese databases. Methodological quality was appraised using A MeaSurement Tool to Assess systematic Reviews 2. Logistic regressions were used to explore associations between bibliographical characteristics and quality.</div></div><div><h3>Results</h3><div>Analyses of methodological quality found that among the 213 sampled SRs, 69.5% were of critically low quality, 30.5% were of low quality, and none achieved high or moderate quality. Common shortcomings included the failure to identify the studies excluded from the analysis, failure to disclose funding sources, and limited evaluation of the potential impact of bias on conclusions. Logistic regressions revealed that SRs led by corresponding authors affiliated with universities or academic institutions tended to be of lower quality than SRs led by authors affiliated with hospitals or clinical facilities.</div></div><div><h3>Conclusion</h3><div>Recent Chinese language CHM SRs exhibited limited methodological quality, making them unlikely to support the development of clinical practice guidelines. Urgent initiatives are needed to enhance training for researchers, peer-reviewers and editors involved in the preparation and publication of SRs. Adoption of Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guidelines in Chinese language journals is crucial to improve the relevance of SRs for Chinese medicine development. Addressing deficiencies in methodology and reporting is essential for promoting evidence-based practices and informed clinical decisions in Chinese medicine.</div><div><br>Please cite this article as: Jiang Y, Zhong CC, Wang BH, Xu SS, Ho FF, Kwong MH, Ho L, Zhou JHS, Lam KC, Liu JP, Zhang BT, Chung VCH. Methodological quality of systematic reviews on orally administered Chinese herbal medicine published in Chinese between 2021 and 2022: A cross-sectional study. <em>J Integr Med</em>. 2025; 23(5):492–501.</div></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"23 5","pages":"Pages 492-501"},"PeriodicalIF":4.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144975104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Integrative Medicine-Jim
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1